Georgia Woman Faces Murder Charge After Allegedly Inducing Abortion with Pills
A 31-year-old woman from Georgia, Alexia Moore, has been charged with murder after allegedly using pills to induce an illegal abortion. This case could set a precedent as it is one of the first instances of a woman facing such charges since the state enacted a law in 2019 that restricts most abortions.
The arrest warrant details that Moore was pregnant beyond six weeks, a critical threshold in Georgia law where embryonic cardiac activity can be detected. Medical staff noted that the fetus had a beating heart and was struggling to breathe at the time of delivery.
“No one should be criminalized for having an abortion,” stated Dana Sussman, senior vice president of the advocacy group Pregnancy Justice, who described Moore’s situation as “an unprecedented murder charge for an alleged abortion.”
On December 30, Moore sought medical attention at a hospital, reporting abdominal pain. She disclosed to medical personnel that she had taken misoprostol, a medication commonly used in abortions, along with oxycodone, an opioid painkiller. The arrest warrant, obtained by local police in Kingsland, indicates that the fetus survived for about an hour post-delivery.
In a troubling admission to nursing staff, Moore reportedly said, “I know my infant is suffering because I am the one who did the abortion. I want her to die.” This statement has raised significant ethical and legal questions regarding the implications of her actions.
Georgia's law prohibits abortions once cardiac activity is detected, typically around six weeks of gestation—often before many women are even aware they are pregnant. Moore has been held in Camden County jail since March 4 on charges of murder and illegal drug possession.
A recent study by Pregnancy Justice revealed that over 210 women across the U.S. faced criminal charges related to their pregnancies in the year following the Supreme Court's decision to overturn Roe v. Wade. This figure represents a significant increase compared to previous years, with many cases involving allegations of substance use during pregnancy.
Moore’s mother declined to comment when contacted, while a representative from the Georgia Public Defender Council confirmed that an attorney is representing her but did not provide further details. Court records indicate that Moore’s attorney has filed motions for bond and a speedy trial, with a hearing scheduled for Monday.
The decision to prosecute Moore will ultimately rest with District Attorney Keith Higgins of the Brunswick Judicial Circuit, who must first secure an indictment from a grand jury. Higgins has not responded to inquiries regarding the case.
The warrant states that medical records estimate Moore was between 22 to 24 weeks pregnant at the time, placing her fetus at the threshold of viability. It refers to the fetus as “a human being who was born alive and survived for one hour,” aligning with Georgia law that recognizes a person at live birth.
Andrew Fleischman, a defense attorney in Georgia not involved in this case, noted that authorities could pursue murder charges against women who terminate pregnancies after cardiac activity is detected. “Murder is intentionally causing the death of a person,” he explained, emphasizing that this legal interpretation was anticipated prior to the law's passage.
Elizabeth Edmonds, executive director of the anti-abortion Georgia Life Alliance, defended the murder charge as appropriate due to Moore's alleged illegal drug use prior to the fetus's death. The warrant indicates that toxicology tests found oxycodone in the fetus's blood; however, misoprostol could not be detected.
Moore reportedly acquired the abortion pills online and obtained oxycodone from a relative. Camden County Coroner M. Wayne Peeples stated he was called to take custody of the remains but did not classify the death as homicide, citing both cause and manner as undetermined.
In addition to murder charges, Moore faces counts for possessing oxycodone without a prescription and for possessing misoprostol, which is classified as a dangerous drug when used for abortion purposes. The combination of misoprostol and mifepristone is FDA-approved for terminating pregnancies within the first ten weeks but can also be used off-label in later stages.
As states grapple with evolving abortion laws, Louisiana has classified mifepristone and misoprostol as controlled substances, with similar proposals emerging in other jurisdictions but yet to be enacted elsewhere.
